EverHint – EMA 10/30 Crossover, SMA 20/50 Crossover, EMA 10 + Price + MACD – Top 17 Buy and Top 10 Sell Signals for Nov 05, 2026
Excerpt: 27 signals (from 121 total). Technology leads (25). price range $8-$605. 5 with insider selling.
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (10 of 32)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ALGT | Allegiant Travel Company | Industrials | $87.59 | — | $2.4B |
| 2 | ALSN | Allison Transmission H... | Consumer Cyclical | $116.45 | — | $9.6B |
| 3 | AMZN | Amazon.com, Inc. | Consumer Cyclical | $260.21 | — | $2813.7B |
| 4 | BCE | BCE Inc. | Communication Services | $22.03 | — | $20.5B |
| 5 | BLBD | Blue Bird Corporation | Consumer Cyclical | $59.19 | — | $1.9B |
| 6 | CAR | Avis Budget Group, Inc. | Industrials | $120.44 | — | $4.3B |
| 7 | CBRE | CBRE Group, Inc. | Real Estate | $136.35 | — | $39.3B |
| 8 | CRI | Carter's Inc. | Consumer Cyclical | $32.64 | — | $1.2B |
| 9 | DB | Deutsche Bank AG | Financial Services | $36.42 | — | $67.5B |
| 10 | DOC | Healthpeak Properties,... | Real Estate | $20.12 | — | $13.9B |
🔴 Sell Signals (5 of 75)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AFRM | Affirm Holdings, Inc. | Financial Services | $69.66 | — | $20.8B |
| 2 | AMG | Affiliated Managers Gr... | Financial Services | $350.54 | — | $9.1B |
| 3 | ARXS | Arxis, Inc. Class A Co... | Industrials | $48.52 | — | $2.0B |
| 4 | BB | BlackBerry Limited | Technology | $8.37 | — | $4.9B |
| 5 | BCC | Boise Cascade Company | Basic Materials | $73.75 | — | $2.6B |
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (5 of 5)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | APPF | AppFolio Inc. | Technology | $233.22 | — | $8.3B |
| 2 | BNS | The Bank of Nova Scotia | Financial Services | $91.77 | — | $111.9B |
| 3 | FOXA | Fox Corporation | Communication Services | $67.67 | — | $28.5B |
| 4 | RGEN | Repligen Corporation | Healthcare | $168.48 | — | $10.8B |
| 5 | ZYME | Zymeworks Inc. | Healthcare | $28.73 | — | $2.1B |
🔴 Sell Signals (5 of 7)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ASX | ASE Technology Holding... | Technology | $29.72 | — | $65.6B |
| 2 | KEX | Kirby Corporation | Industrials | $119.47 | — | $6.3B |
| 3 | META | Meta Platforms, Inc. | Communication Services | $605.08 | Sell -$250,573 | $1339.9B |
| 4 | NOW | ServiceNow, Inc. | Technology | $102.36 | — | $106.2B |
| 5 | NTNX | Nutanix, Inc. | Technology | $58.55 | — | $15.8B |
Insider selling (7d): META (-$250,573)
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (2 of 2)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | ADMA | ADMA Biologics, Inc. | Healthcare | $13.21 | — | $3.0B |
| 2 | EWTX | Edgewise Therapeutics,... | Healthcare | $38.87 | — | $4.2B |
Recent Headlines
AFRM (Affirm Holdings, Inc.)
- Affirm Holdings (AFRM) Q1 Earnings and Revenues Beat Estimates
- Affirm Earnings Beat. Shares Fall As Consumer Credit Quality Worsens.
AMZN (Amazon.com, Inc.)
- Stock Market Today, Nov. 5: Amazon Shares Slide as Technology Selloff Erases Early Gains
KEX (Kirby Corporation)
- Kirby McInerney LLP Alerts Investors Who Acquired Duolingo, Inc. DUOL Securities Between May 2, 2025 and February 26, 2026 of Pending Lawsuit
- Kirby McInerney LLP Alerts Investors Who Acquired The Ensign Group, Inc. ENSG Securities Between February 10, 2022 and June 18, 2026 of Pending Lawsuit
META (Meta Platforms, Inc.)
- Google, Meta and TikTok Sue California Over Ban on Features for Kids
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 If you found this useful, a quick like, share, or subscribe keeps EverHint moving forward.